BioCentury | Feb 8, 2019
Company News

Management tracks: Takeda’s Plump becomes president of R&D

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) Andrew Plump has become president of R&D, according to the pharma's website. He was Takeda's CMO and CSO since 2015. Wolfram Nothaft, former head of global clinical development at...
BioCentury | Sep 8, 2014
Company News

Moberg Pharma management update

Moberg Pharma AB (SSE:MOB), Bromma, Sweden Business: Dermatology, Neurology Resigning: Steve Cagle as head of U.S. operations, effective January 2015 at the latest WIR Staff Dermatology Neurology...
BioCentury | Jun 17, 2013
Company News

GrayBug management update

GrayBug LLC , Baltimore, Md. Business: Drug delivery, Ophthalmic Hired: Gerald Cagle as a senior advisor and head of business development, formerly SVP and CSO of Alcon Inc. , which Novartis AG acquired WIR Staff...
BioCentury | Dec 22, 2008
Company News

Neuroptix management update

Neuroptix Corp. , Acton, Mass. Business: Diagnostic, Supply/Service Hired: Gerald Cagle as COO, formerly SVP of R&D and CSO at Alcon Inc. subsidiary Alcon Laboratories, Inc. WIR Staff...
BioCentury | Jan 31, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Gastric cancer; gastrointestinal cancer Cytotoxin-associated gene A (CagA) Studies in mice suggested that targeting the Helicobacter pylori protein CagA could be...
BioCentury | Aug 17, 1998
Clinical News

Biomerica, OraVax regulatory update

ORVX received U.S. Patent No. 5,733,740 covering a method of detecting antibodies against the Cytotoxin Associated Gene A ( CagA ) protein expressed only by virulent strains of H. pylori. BMRA has an exclusive license to the...
BioCentury | Apr 20, 1998
Company News

Biomerica, OraVax deal

BMRA acquired an exclusive license to ORVX's Cytotoxin Associated Gene A ( CagA ) for diagnostic use. BMRA will develop physician office and clinical laboratory tests based on CagA to detect H. pylori. ORVX is eligible for...
BioCentury | Aug 8, 1994
Company News

Embrex sales and marketing update

EMBX (Research Triangle Park) entered into agreements with Hudson Foods Inc. (Rogers, Ark.) and Cagle's Inc. (Atlanta) to use EMBX's Inovoject egg injection vaccination system in one or more of their hatcheries. EMBX said Hudson...
Items per page:
1 - 8 of 8